IDH3α was also considered to be an upstream activator of hypoxia-inducible factor-1, which promotes metabolic reprogramming of cancer cells and angiogenesis of malignant tumors by improving the stability and transactivation of hypoxia-inducible factor-1 (19). This evidence concerns the gene IDH3A and cancer.